Dr John McHutchison

Dr John McHutchison


Chief Executive Officer and President
Assembly Biosciences, Inc.
Corresponding Fellow
Elected in 2018
Citation on election

Many researchers have contributed to the discovery of therapies offering permanent cure for virtually all Hepatitis C Virus (HCV) infected patients. However, none has been leading the field in all its incremental and seminal stages more than Dr. McHutchison. His intellectual and clinical research talents resulted in him developing the antiviral drug combinations, Sovaldi®, Harvoni® and the pan-genotypic Epclusa® that collectively cure nearly every patient infected with HCV. The importance of this accomplishment cannot be overstated: cure of any disease is a major achievement.

Keep up to date with the latest news

By providing your email address, you consent to it being added to our mailing list.